Evidence map›Paper›PMID 29463588›Full record

ArticleBMJ open2018

Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol.

XingRong Shen, MengJie Diao, ManMan Lu, Rui Feng, PanPan Zhang, Tao Jiang, DeBin Wang

Abstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Reply to: Letter on "Objective and subjective financial burden and health-related quality of life among lung cancer patients" by Joohyun Park.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

XingRong ShenSchool of Health Services Management, Anhui Medical University, Hefei, Anhui, China.
MengJie DiaoSchool of Health Services Management, Anhui Medical University, Hefei, Anhui, China.
ManMan LuSchool of Health Services Management, Anhui Medical University, Hefei, Anhui, China.
Rui FengDepartment of Literature Review and Analysis, Library of Anhui Medical University, Hefei, Anhui, China.
PanPan ZhangSchool of Health Services Management, Anhui Medical University, Hefei, Anhui, China.
Tao JiangSchool of Health Services Management, Anhui Medical University, Hefei, Anhui, China.
DeBin WangSchool of Health Services Management, Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-9708-9659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRoutine inpatient care (RIC) for patients with cancer forms various pathways of clinical procedures. Although most individual procedures comprising the pathways have been tested via clinical trials, little is known about the collective cost and effectiveness of the pathways as a whole. This study aims at exploring RIC pathways for patients with lung cancer from rural Anhui, China, and their determinants and economic impacts. METHODS AND ANALYSIS: The study adopts a retrospective cohort design and proceeds in five steps. Step 1 defines the four main categories of study variables, including clinical procedures, direct cost and effectiveness of procedures, and factors affecting use of these procedures and their cost and effectiveness. Step 2 selects a cohort of 5000 patients with lung cancer diagnosed between 1 July 2015 and 30 June 2016 from rural Anhui by clustered random sampling. Step 3 retrieves the records of all the inpatient care episodes due to lung cancer and extracts data about RIC procedures, proximate variables (eg, Karnofsky Performance Status, Lung Function Score) of patient outcomes and related factors (eg, stage of cancer, age, gender), by two independent clinician researchers using a web-based form. Step 4 estimates the direct cost of each of the RIC procedures using micro-costing and collects data about ultimate patient outcomes (survival and progression-free survival) through a follow-up survey of patients and/or their close relatives. Step 5 analyses the data collected and explores pathways of RIC procedures and their relations with patient outcomes, costs, cost:effect ratios, and a whole range of clinical and sociodemographic factors using multivariate regression and path models. ETHICS AND DISSEMINATION: The study protocol has been approved by an authorised ethics committee of Anhui Medical University (reference number: 20170312). Findings from the study will be disseminated through conventional academic routes such as peer-reviewed publications and presentations at regional, national and international conferences. TRIAL REGISTRATION NUMBER: ISRCTN25595562.

Indexed as

Critical PathwaysInpatientsChinaCost-Benefit AnalysisHealth Care CostsHumansLung NeoplasmsRegression AnalysisRetrospective Studieschinacost effectivenessinpatient carelung cancerretrospective study

Identifiers

PMID29463588
PMCPMC5879485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.